Publicité
Publicité

SLXN

SLXN logo

Silexion Therapeutics Corp Ordinary Shares

2.12
USD
Sponsorisé
+0.02
+0.95%
09 janv., 15:12 UTC -5
Fermé
exchange

Après-marché

2.09

-0.03
-1.60%

SLXN Rapports sur les bénéfices

Ratio de surprise positive

SLXN a dépassé 2 des 5 dernières estimations.

40%

Prochain rapport

Date du prochain rapport
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Variation implicite de Q3 25 (Revenue/ EPS)
--
/
--
Variation implicite de Q-- -1 (Revenue/ EPS)
--
/
--

Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue

On 12 nov. 2025, SLXN reported earnings of -2.88 USD per share (EPS) for Q3 25, beating the estimate of -3.46 USD, resulting in a 16.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.56% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$2.88, beating estimates by 16.96%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.56%, changed from $2.81 before the earnings release to $2.91 the day after.
The next earning report is scheduled for --.
Based on -- analystes, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité